Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway

dc.contributor.authorGarcía Rizo, Clemente
dc.contributor.authorKirkpatrick, Brian
dc.contributor.authorFernández-Egea, Emilio
dc.contributor.authorOliveira, Cristina
dc.contributor.authorBernardo Arroyo, Miquel
dc.date.accessioned2019-03-21T18:00:29Z
dc.date.available2019-03-21T18:00:29Z
dc.date.issued2016-05-01
dc.date.updated2019-03-21T18:00:29Z
dc.description.abstractObjective: Patients with serious mental illnesses exhibit a reduced lifespan compared with the general population, a finding that can not solely rely on high suicide risk, low access to medical care and unhealthy lifestyle. The main causes of death are medical related pathologies such as type 2 diabetes mellitus and cardiovascular disease; however pharmacological treatment might play a role. Material and methods: We compared a two hour glucose load in naïve patients at the onset of a serious mental illness (N = 102) (84 patients with a first episode of schizophrenia and related disorders, 6 with a first episode of bipolar I disorder and 12 with a first episode of major depression disorder) with another psychiatric diagnose, adjustment disorder (N = 17) and matched controls (N = 98). Results: Young patients with serious mental illness showed an increased two hour glucose load compared with adjustment disorder and the control group. Mean two hour glucose values [±standard deviation] were: for schizophrenia and related disorders 106.51 mg/dL [±32.0], for bipolar disorder 118.33 mg/dL [±34.3], for major depressive disorder 107.42 mg/dL [±34.5], for adjustment disorder 79.06 mg/dL[±24.4] and for the control group 82.11 mg/dL [±23.3] (p < 0.001). Conclusions: Our results reflect an abnormal metabolic pathway at the onset of the disease before any pharmacological treatment or other confounding factors might have taken place. Our results suggest a similar glycemic pathway in serious mental illnesses and the subsequent need of primary and secondary prevention strategies.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec665724
dc.identifier.issn0306-4530
dc.identifier.pmid26878465
dc.identifier.urihttps://hdl.handle.net/2445/130727
dc.language.isoeng
dc.publisherElsevier Ltd
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.psyneuen.2016.02.001
dc.relation.ispartofPsychoneuroendocrinology, 2016, vol. 67, p. 70-75
dc.relation.urihttps://doi.org/10.1016/j.psyneuen.2016.02.001
dc.rightscc-by-nc-nd (c) Elsevier Ltd, 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationTrastorn bipolar
dc.subject.classificationEsquizofrènia
dc.subject.classificationDepressió psíquica
dc.subject.classificationMortalitat
dc.subject.otherManic-depressive illness
dc.subject.otherSchizophrenia
dc.subject.otherMental depression
dc.subject.otherMortality
dc.titleAbnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
665724.pdf
Mida:
288.67 KB
Format:
Adobe Portable Document Format